. 2020 Aug 28;26(32):4817–4832. doi: 10.3748/wjg.v26.i32.4817

Table 3.

The comparison of human leukocyte antigen alleles which increase or decrease the gastric cancer risk in gastric cancer subgroup cases in terms of CagA+ (≥ 2) EPIYA-C, n (%)

	GC (≥ 2) EPIYA-C (n = 26, alleles = 52)	GC (< 2) EPIYA-C (n = 18, alleles = 36)	OR	95%CI			P value
	GC (≥ 2) EPIYA-C (n = 26, alleles = 52)	GC (< 2) EPIYA-C (n = 18, alleles = 36)	OR	Minimum	Maximum		P value
HLA-A*02	12 (23)	10 (27)	0.78	0.29		2.06	0.6170
HLA-B*35	12 (23)	10 (27)	0.78	0.29		2.06	0.6170
HLA-DRB1*13	12 (23)	12 (33)	0.60	0.23		1.54	0.2903
HLA-DQA1*01	24 (46)	16 (44)	1.07	0.45		2.51	0.8742
HLA-DQB1*06	12 (23)	16 (44)	0.37	1.14		2.90	0.0369

HLA: Human leukocyte antigen; GC: Gastric cancer; CI: Confidence interval; OR: Odds ratio.